qPCR Testing for GI Pathogens
Wednesday, January 13, 2021
Methodology Matters in Diagnostic Stool Testing
By David M. Brady, ND, DC, CCN, DACBN, IFMCP, FACN and Cass Nelson-Dooley, MS
Our Chief Medical Officer, Dr. David Brady, is featured on the cover of the January 2021 issue of the Townsend Letter. Read the article, "Methodology Matters in Diagnostic Stool Testing."
Dr. Brady describes the different methodologies used to evaluate gut health and why qPCR offers the most sensitive, specific, reliable results when addressing acute and chronic gastrointestinal illness in a clinical setting.
Article highlights:
- Molecular Methods Revolutionize Diagnostic Testing
- Methods of Stool Testing Defined
- Culture and Microscopic Methodologies
- Advantages of Quantitative Molecular (qPCR) Technology in Clinical Settings
- Discussion – The Molecular Revolution
- References
Please Note: This button opens the article in a new window on the Townsend Letter site.
Seriously, every single person NEEDS to have this test done. I mean need, not have to, NEED to! The GI-MAP test gives so much insight into your health and your symptoms ... I’m finding this test to be a non-negotiable with my clients since it takes the guesswork out of what protocols I am going to explore with them.
- Clinician comment via Facebook
Results You Can Rely On
Research indicates that gut health impacts every area of human health.
Optimal health – it all starts with the GI-MAP ™ – Comprehensive DNA Stool Analysis via qPCR.